 Biotech stocks staged a nice recovery along with the broader markets in the week ended April 17.Apart from the broader market sentiment, big moves in biopharma companies such as Johnson Johnson NYSE: JNJ and Gilead Sciences, Inc. NASDAQ: GILD also supported sentiment. The former reported strongly 